Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 4

Brains Bioceutical Announces $750M Deal for Proposed Nasdaq Listing

Nov 6, 2026
Brains Bioceutical Corp. has entered into a definitive business combination agreement with Armada Acquisition Corp. III, a publicly traded special purpose acquisition company (SPAC), in…
Read More...

Lonza to Acquire Five US Manufacturing Sites from Merck KGaA

Nov 5, 2026
Lonza, a Switzerland-based contract development and manufacturing organization (CDMO), has signed an agreement to acquire five manufacturing sites from Germany's Merck KGaA in a deal…
Read More...

FDA Accepts uniQure’s Gene Therapy Application for Huntington’s Disease

Nov 5, 2026
uniQure N.V. has received an important regulatory milestone in its effort to develop a gene therapy for Huntington’s disease after the US Food and Drug Administration (FDA) accepted its…
Read More...

Circular Genomics Partners with PharmatrophiX on Alzheimer’s Biomarkers

Nov 5, 2026
Circular Genomics and PharmatrophiX have announced a strategic collaboration to use blood-based circular RNA (circRNA) biomarkers to support the development of new treatments for…
Read More...

Fresenius Partners with WuXi Biologics to Expand Biosimilar Pipeline

Nov 4, 2026
Fresenius SE & Co. KGaA has entered into an exclusive development agreement with WuXi Biologics to expand its biosimilar drug pipeline, with access to up to 37 potential new…
Read More...

Bavarian Nordic Wins Four-Year UK Vaccine Supply Contract

Nov 4, 2026
Bavarian Nordic has secured a new four-year vaccine supply contract from the UK government to support the country's preparedness against mpox and smallpox outbreaks. Announced on…
Read More...

FDA Issues New Guidance for Cell and Gene Therapy Development

Nov 4, 2026
The US Food and Drug Administration (FDA) has issued new final guidance to help pharmaceutical and biotechnology companies improve the development, manufacturing and quality control of…
Read More...

Allergan Aesthetics to Present New Weight Loss Research at ASDS 2026

Nov 4, 2026
Allergan Aesthetics, an AbbVie company, will present new research on aesthetic treatments for people experiencing medical weight loss at the 2026 American Society for Dermatologic…
Read More...

FDA Approves First Plasmid DNA Immunotherapy for Recurrent Respiratory Papillomatosis

Nov 2, 2026
The US Food and Drug Administration (FDA) has granted accelerated approval to Inovio Pharmaceuticals’ Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for adults…
Read More...

Pelthos to Merge with Castle Creek in Rare Skin Disease Push

Nov 2, 2026
Pelthos Therapeutics and Castle Creek Biosciences have agreed to merge, bringing together their dermatology products and cell and gene therapy programmes to develop treatments for…
Read More...
Previous 1 2 3 4 5 6 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.